Togha 2014.
Methods | Single‐centre, double‐blind, randomised trial done in Iran |
Participants | Chronic migraine according to IHS. Number of participants not reported |
Interventions | Venlafaxine 150 mg; topiramate 100 mg |
Outcomes | Not reported |
Notes | — |
IHS: International Headache Society